These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2198852)

  • 1. [Arteriosclerosis obliterans. Treatment with angiotensin-converting enzyme inhibitors].
    Orea A; Valdés R; Niebla L; Rivas R; Camacho B
    Arch Inst Cardiol Mex; 1990; 60(2):183-90. PubMed ID: 2198852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the efficacy of captopril and enalapril in single doses in the treatment of arterial hypertension. Evaluation by means of non-invasive ambulatory monitoring].
    Valori C; Gambini G; Canini F; Marinelli M; Rossi S; Pinchi G
    Clin Ter; 1989 Jul; 130(1):37-44. PubMed ID: 2551565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the cardiac and peripheral vascular effects of the administration of single-dose enalapril and captopril in essential arterial hypertension].
    Longhini C; Ansani L; Musacci GF; Vaccari M; Fraccaroli GP; Mele D; Aggio S; Baracca E
    Cardiologia; 1989 Jan; 34(1):61-7. PubMed ID: 2541907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE; Sjöstrand A; Ohman KP
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and hemodynamic effects of captopril in patients with arterial hypertension and obliterative arteriopathy of the legs].
    Bolognini G; Iezzi Biase G
    Clin Ter; 1986 Feb; 116(4):287-9. PubMed ID: 3516544
    [No Abstract]   [Full Text] [Related]  

  • 7. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Speed of propagation of the rheographic wave in the lower extremities in normal subjects, patients with arteriosclerosis obliterans and subjects with peripheral arterial sclerosis].
    Di Renzi L; Leggio F; Cassone R; Lucisano V; Gambelli G
    Riv Med Aeronaut Spaz; 1970; 33(3):307-29. PubMed ID: 5513754
    [No Abstract]   [Full Text] [Related]  

  • 9. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
    Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
    Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial regional circulation of the lower extremities studied with the rheographic method and with albumin labeled with I-131].
    Modica G; Sorrentino F; Musco A
    Boll Soc Ital Cardiol; 1966; 11(4):1078-92. PubMed ID: 4867624
    [No Abstract]   [Full Text] [Related]  

  • 15. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
    Okuro M; Morimoto S; Takahashi T; Okaishi K; Nakahashi T; Murai H; Iwai K; Kanda T; Matsumoto M
    Hypertens Res; 2006 Sep; 29(9):655-63. PubMed ID: 17249520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B; Vajo Z; Dachman W
    Acta Physiol Hung; 1996; 84(4):361-7. PubMed ID: 9328608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ
    Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.